Format

Send to

Choose Destination
N Engl J Med. 2019 May 30;380(22):2178-2180. doi: 10.1056/NEJMc1815121.

Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.

Author information

1
Stellenbosch University, Cape Town, South Africa margab@sun.ac.za.
2
Translational Genomics Research Institute, Flagstaff, AZ.
3
Stellenbosch University, Cape Town, South Africa.
4
Médecins sans Frontières, Cape Town, South Africa.
5
National Health Laboratory Services, Cape Town, South Africa.
6
Centers for Disease Control and Prevention, Atlanta, GA.
7
Critical Path Institute, Tucson, AZ.
8
University of California, San Francisco, San Francisco, CA.
9
University of Antwerp, Antwerp, Belgium.
10
South African Medical Research Council, Cape Town, South Africa.
11
University of Cape Town, Cape Town, South Africa.
PMID:
31141643
PMCID:
PMC6518951
DOI:
10.1056/NEJMc1815121
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center